Market Research Logo

Global Stem Cell Umbilical Cord Blood Market 2015-2019

Global Stem Cell Umbilical Cord Blood Market 2015-2019

About Stem Cell UCB

UCB is the blood that remains in the placenta and the attached umbilical cord after childbirth. UCB contains stem cells that are unique, smart, and are capable of treating several life-threatening diseases. They are used in the treatment of hematopoietic and genetic disorders. The placental blood can produce 10 times more quantity of stem cells compared to the umbilical cord, which can in turn be used for the treatment of an adult patient. The cord blood that is collected during the childbirth is stored and cryopreserved. The storage of the cord blood can be done at private cord blood banks or public cord blood banks. This preserved blood can be used for the transplantation, and treatment of diseases at the later stages of life.

Technavio's analysts forecast the global stem cell UCB market to grow at a CAGR of 30.36% over the period 2014-2019.

Covered in this Report

The report covers the present scenario and the growth prospects of the global stem cell UCB market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the banking and utilization of UCB stem cells for the treatment of various disorders, such as cancers, blood disorders, metabolic disorders, immune diseases, and others.

Technavio's report, Global Stem Cell UCB Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global stem cell UCB market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.Key Regions

  • Americas
  • APAC
  • EMEA
Key Vendors
  • Caladrius Biosciences
  • Celgene
  • Mesoblast
  • Pluristem Therapeutics
Other Prominent Vendors
  • Athersys
  • CHA Bio & Diostech
  • Cytori Therapeutics
  • Nuo Therapeutics
  • Ocata Therapeutics
  • Opexa Therapeutics
  • Osiris Therapeutics
  • Teva Pharmaceuticals
  • United Therapeutics
Key Market Driver
  • Effective Treatment of Life-threatening Diseases
  • For a full, detailed list, view our report
Key Market Challenge
  • Stringent Regulations
  • For a full, detailed list, view our report
Key Market Trend
  • Growing Public Awareness
  • For a full, detailed list, view our report
Key Questions Answered in this Report
  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Stem Cell Umbilical Cord Blood (UCB) Market 2015-2019

Technavio recognizes the following companies as the key players in the Global Stem Cell Umbilical Cord Blood Market: Caladrius Biosciences, Celgene, Mesoblast and Pluristem Therapeutics

Other Prominent Vendors in the market are: Athersys, CHA Bio & Diostech, Cytori Therapeutics, Nuo Therapeutics, Ocata Therapeutics, Opexa Therapeutics, Osiris Therapeutics, Teva Pharmaceuticals and United Therapeutics

Commenting on the report, an analyst from Technavio’s team said: “Public awareness of stem cell UCB banking is increasing due to the various awareness programs conducted. This is done with the motive of making people aware of the potential benefits of cord blood banking. It will result in social and economic benefits as well. At the events, the idea is to educate people about the importance of cord blood banking. This is vital because it can help in the improvement of the quality of life of many patients suffering from life-threatening diseases. Companies such as Americord and Viacord are promoting July as National Stem Cell Awareness month. Similarly, Precious Cells surveyed 1,000 families in UK with children under the age of 10, as part of the National Stem Cell Awareness Day on October 8, 2014. To increase the awareness of cord blood banking, Save the Cord Foundation is partnering with Bioinformant. Also, LifeCell is creating awareness among in India about the need for umbilical cord stem cell banking. These programs help in promoting awareness for present and future stem cell treatments.”

According to the report, UCB stem cells prove to be an effective treatment option for more than 80 diseases, such as cancer, immunodeficiency disorders, and blood disorders. Many of these diseases, which have no cure, can be treated effectively with the use of stem cells obtained from the umbilical cord. These stem cells travel to the site of damage and identify the defective cells. They then initiate a healing process and are thus used in the treatment. Since they are derived from the same individual, the risk of rejection can also be eliminated. Research is being carried out for the development of UCB stem cells as an effective treatment option for diseases such as diabetes, Alzheimer's disease, brain tumor, and heart failure. They can thus be used as a successful mode of treatment for many of life-threatening diseases.

Further, the report states that accreditations and stringent rules may pose a challenge, as not all hospitals will be able to collect and store the cord blood.

Companies Mentioned

Caladrius Biosciences, Celgene, Mesoblast, Pluristem Therapeutics, Athersys, CHA Bio & Diostech, Cytori Therapeutics, Nuo Therapeutics, Ocata Therapeutics, Opexa Therapeutics, Osiris Therapeutics, Teva Pharmaceuticals, United Therapeutics

  • Executive Summary
  • List of Abbreviations
  • Scope of the Report
    • Market Overview
  • Market Research Methodology
    • Market Research Process
    • Research Methodology
      • Table Market Research Methodology
  • Introduction
  • Process of Collection, Processing, and Storage of Cord Blood Cells
    • Donor Evaluation
      • Table Donor Evaluation before Collection of Cord Blood Cells
    • Collection Methods
      • Table Collection of Cord Blood Cells
    • Processing and Storage Methods
      • Table Processing and Storage Methods of Cord Blood Cells
    • Sample Retention and Length of Storage
  • Facts: Cord Blood Units
    • Table Stem Cell Transplantations by Patient Race in US
  • US FDA Approved Stem Cell UCB Product
    • Hemacord
      • Mechanism of Action
      • Side Effects
  • Pipeline Analysis
    • Table Pipeline Portfolio of Stem Cell UCB Products for Different Diseases
    • Information on Pipeline Candidates
      • PDA-002
      • PDA-001
      • PLX-PAD
      • PLX-R18
  • Market Landscape
    • Market Overview
    • Market Size and Forecast
      • Table Global Stem Cell UCB Market 2014-2019 ($ millions)
    • Five Forces Analysis
  • Market Segmentation by Application
    • Table Global Stem Cell UCB Market Segment by Application
    • Cancers
    • Blood Disorders
    • Metabolic Disorders
    • Immune Disorders
    • Others
  • Market Segmentation by Storage
    • Table Global Stem Cell UCB Market Segmentation by Storage
    • Public Cord Blood Bank
    • Private Cord Blood Bank
    • Public-Private Cord Blood Banks
  • Harmonization of Biobanking
    • Table Organizations and Initiatives Toward Biobank Harmonization
    • Table Key Factors Involved in Harmonization of Biobanks
    • Table Key Focus Areas in Harmonization of Biobanks
    • Table Organizations and Initiatives in Harmonizing Science and Infrastructure
    • Table Initiatives on Biobanking Resource Tools and Databases
  • Market Segmentation by End-user
    • Table Global Stem Cell UCB Market Segment by End-user
    • Research Institutes
    • Pharmaceutical Companies
    • Biobanks
    • Hospitals
  • Geographical Segmentation
    • Table Segmentation of Global Stem Cell UCB Market by Geography 2014
    • Stem Cell UCB Market in Americas
      • Market Size and Forecast
        • Table Stem Cell UCB Market in Americas 2014-2019 ($ millions)
    • Stem Cell UCB Market in EMEA
      • Market Size and Forecast
        • Table Stem Cell UCB Market in APAC 2014-2019 ($ millions)
    • Stem Cell UCB Market in APAC
      • Market Size and Forecast
        • Table Stem Cell UCB Market in APAC 2014-2019 ($ millions)
        • Table Statistics of Stem Cell UCB Market by Geography
  • Buying Criteria
  • Market Growth Drivers
  • Drivers and their Impact
  • Market Challenges
  • Impact of Drivers and Challenges
  • Market Trends
  • Trends and their Impact
  • Vendor Landscape
    • Competitive Scenario
      • Key News
      • Mergers and Acquisitions
    • Market Share Analysis 2014
      • Caladrius Biosciences
      • Celgene Corp.
      • Mesoblast Ltd.
      • Pluristem Therapeutics
    • Other and Future Prominent Vendors
  • Global Stem Cell UCB Market: Key Takeaways
    • Table Global Stem Cell UCB Market: Key Takeaways
  • Key Vendor Analysis
    • Caladrious
      • Key Facts
      • Business Overview
      • Business Segmentation by Revenue 2014
        • Table Caladrious: Business Segmentation by Revenue 2014
      • Business Segmentation by Revenue 2013 and 2014
        • Table Caladrious: Business Segmentation by Revenue 2013 and 2014 ($ millions)
      • Geographical Segmentation by Revenue 2014
        • Table Caladrious: Geographical Segmentation by Revenue 2014
      • Business Strategy
      • Recent Developments
      • SWOT Analysis
    • Celgene
      • Key Facts
      • Business Overview
      • Business Strategy
      • Business Segmentation by Revenue
        • Table Celgene: Business Segmentation by Revenue 2011-2013 ($ millions)
      • Sales by Geography
        • Table Celgene: Sales by Geography 2013
      • Key Information
      • SWOT Analysis
    • Mesoblast
      • Key Facts
      • Business Overview
      • Therapeutic Areas
        • Table Mesoblast: Therapeutic Areas
      • Geographical Segmentation
        • Table Mesoblast: Geographical Segmentation
      • Business Strategy
      • Recent Developments
      • SWOT Analysis
    • Pluristem
      • Key Facts
      • Business Overview
      • Geographical Presence
        • Table PLuristem: Geographical Presence
      • Business Strategy
      • Recent Developments
      • SWOT Analysis
  • Other Reports in this Series

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report